Opportunity Information: Apply for RFA RM 18 021
The Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) funding opportunity (RFA-RM-18-021) is a National Institutes of Health (NIH) discretionary grant mechanism designed to support small, focused pilot studies on a specific set of hard-to-study biological targets. The scientific emphasis is on "IDG-eligible" understudied proteins within three major target families that are central to modern biomedical research and drug discovery: non-olfactory G protein-coupled receptors (GPCRs), protein kinases, and ion channels. The goal is to push research on these less-characterized proteins beyond what the NIH-supported IDG Centers can accomplish on their own, while also showing, in real experimental settings, how useful the IDG program's reagents, datasets, and methodological approaches can be when used by the broader research community.
At a practical level, the opportunity is aimed at enabling early, proof-of-concept work that can clarify whether an understudied receptor, channel, or kinase has meaningful biological function, disease relevance, tractable pharmacology, or potential as a therapeutic target. Because it uses the R03 mechanism, projects are expected to be limited in scope, tightly justified, and structured to produce clear, interpretable outputs rather than large-scale multi-aim programs. Another core purpose is "validation" and "demonstration of utility" of IDG resources, meaning applicants are expected to leverage IDG-generated tools (such as chemical probes, antibodies, constructs, assays, interaction maps, omics datasets, or computational resources) and show that these assets can drive credible discovery when applied to specific understudied proteins. The clinical trial prohibition indicates that the proposed work must not include clinical trial activities; the intent is preclinical, mechanistic, tool-building, or target-characterization research rather than prospective interventional studies in humans.
The award information provided for this opportunity lists an award ceiling of $100,000, which signals that budgets should be modest and that the studies should be designed to be feasible within that funding limit. The activity category is Health under CFDA 93.310, and the instrument type is a Grant. The posted original closing date for applications was 2018-10-26, with a creation date of 2018-07-20, which places this as a time-bounded solicitation from that period rather than an always-open announcement.
Eligibility is broad across many types of U.S.-based organizations and government entities. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (as long as they are not institutions of higher education when applying in those nonprofit categories); for-profit organizations other than small businesses; and small businesses. The solicitation also explicitly highlights additional eligible applicant categories, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
The announcement draws an important distinction regarding foreign involvement. While it references non-domestic (non-U.S.) entities in the list of "other eligible applicants," it then clarifies that non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply, and that non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed. In typical NIH terms, this means a U.S. applicant organization can include certain justified international collaborations or subcomponents (for example, a specific overseas site performing a defined set of experiments) as part of the project, but the primary applicant institution must be eligible and U.S.-based, and the structure must comply with NIH rules governing foreign components.
Overall, this opportunity is best understood as a targeted NIH pilot funding call meant to accelerate basic and translationally relevant knowledge about understudied GPCRs, ion channels, and kinases by enabling small, high-impact experiments. It is structured to broaden participation beyond the IDG Centers, spread the use of IDG tools and data throughout the community, and generate early findings and validated approaches that can support larger follow-on studies in future funding mechanisms.Apply for RFA RM 18 021
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.310.
- This funding opportunity was created on 2018-07-20.
- Applicants must submit their applications by 2018-10-26. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $100,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of Behavioral and Social Sciences and STEM Disciplines (K18 Independent Clinical Trial Required)
Previous opportunity: Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA RM 18 021
Applicants also applied for:
Applicants who have applied for this opportunity (RFA RM 18 021) also looked into and applied for these:
| Funding Opportunity |
|---|
| Pre-Application: Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (X02 Clinical Trial Not Allowed) Apply for PAR 18 866 Funding Number: PAR 18 866 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed) Apply for RFA RM 18 030 Funding Number: RFA RM 18 030 Agency: National Institutes of Health Category: Health Funding Amount: $8,000,000 |
| Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed) Apply for PA 18 867 Funding Number: PA 18 867 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed) Apply for PA 18 868 Funding Number: PA 18 868 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Innovations for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33 Clinical Trial Not Allowed) Apply for RFA AR 19 012 Funding Number: RFA AR 19 012 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed) Apply for PA 18 873 Funding Number: PA 18 873 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed) Apply for RFA AI 18 029 Funding Number: RFA AI 18 029 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed) Apply for PA 18 872 Funding Number: PA 18 872 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed) Apply for PA 18 874 Funding Number: PA 18 874 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 18 023 Funding Number: RFA RM 18 023 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R01 - Clinical Trial Not Allowed) Apply for PAR 18 875 Funding Number: PAR 18 875 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovative Technologies to Non-Invasively Monitor Genome Edited Cells In Vivo (UH2/UH3 Clinical Trial Not Allowed) Apply for RFA RM 18 025 Funding Number: RFA RM 18 025 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Center for ELSI Resources and Analysis (U24 Clinical Trial Not Allowed) Apply for RFA HG 18 008 Funding Number: RFA HG 18 008 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) Apply for PAR 18 878 Funding Number: PAR 18 878 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional) Apply for PAR 18 879 Funding Number: PAR 18 879 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Data Coordinating Center (U24- Clinical Trial Not Allowed) Apply for RFA HL 19 022 Funding Number: RFA HL 19 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early Psychosis Intervention Network (EPINET): Data Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA MH 19 151 Funding Number: RFA MH 19 151 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Early Psychosis Intervention Network (EPINET): Practice-Based Research to Improve Treatment Outcomes (R01 Clinical Trial Optional) Apply for RFA MH 19 150 Funding Number: RFA MH 19 150 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Genomic Innovator Award (R35 Clinical Trial Optional) Apply for RFA HG 18 006 Funding Number: RFA HG 18 006 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| HIV Services and Systems Strengthening (HS3) Apply for 72051718RFA00003 Funding Number: 72051718RFA00003 Agency: Dominican Republic USAID-Santo Domingo Category: Health Funding Amount: $19,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA RM 18 021", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
